Filing metadata

Accession number
0001214659-21-003635
Form type
Form 3
Filer
Mirati Therapeutics, Inc.
CIK
CIK 1576263
Filed
Mar 30, 2021
Reporting period
Mar 26, 2021
Description
Initial ownership

Explore SEC Filings Hub